Retrospective Cohort Study
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Jun 27, 2022; 14(6): 567-579
Published online Jun 27, 2022. doi: 10.4240/wjgs.v14.i6.567
Transjugular intrahepatic portosystemic shunt with radioactive seed strand for main portal vein tumor thrombosis with cirrhotic portal hypertension
Xuan-Hui Yan, Zhen-Dong Yue, Hong-Wei Zhao, Lei Wang, Zhen-Hua Fan, Yi-Fan Wu, Ming-Ming Meng, Ke Zhang, Li Jiang, Hui-Guo Ding, Yue-Ning Zhang, Yong-Ping Yang, Fu-Quan Liu
Xuan-Hui Yan, Fu-Quan Liu, Department of Interventional Therapy, Peking University Ninth School of Clinical Medicine, Beijing Shijitan Hospital, Beijing 100038, China
Zhen-Dong Yue, Lei Wang, Zhen-Hua Fan, Yi-Fan Wu, Fu-Quan Liu, Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China
Hong-Wei Zhao, Department of Interventional Therapy, Beijing Tongren Hospital, Capital Medical University, Beijing 100005, China
Ming-Ming Meng, Department of Gastroenterology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China
Ke Zhang, Li Jiang, Department of General Surgery, Beijing Ditan Hospital, Capital Medical University, Beijing 100102, China
Hui-Guo Ding, Department of Gastroenterology, Beijing You'an Hospital, Capital Medical University, Beijing 100069, China
Yue-Ning Zhang, Department of Liver Disease Digestion Center, Beijing You'an Hospital, Capital Medical University, Beijing 100069, China
Yong-Ping Yang, Department of Liver Disease, The Fifth Medical Center of Chinese PLA General Hospital, Beijing 100039, China
Author contributions: Liu FQ designed the research; Yue ZD, Zhao HW, Wang L, Fan ZH, Wu YF, Meng MM, Zhang K, Jiang L, Ding HG, Zhang YN and Yang YP performed the research; Yan XH analyzed the data and wrote the paper; Liu FQ reviewed and edited the manuscript; all authors read and approved the manuscript.
Supported by Beijing Municipal Science and Technology Commission project, The Capital of The Public Health Cultivation, No. Z171100000417031; The Capital Health Research and Development of Special, Beijing Municipal Health Commission, No. 2018-1-2081; and Scientific Research Common Program of Beijing Municipal Commission of Education, No. KM201810025028 (to Liu FQ).
Institutional review board statement: The study was reviewed and approved by the Ethics Committee and Institutional Review Board of Peking University Ninth School of Clinical Medicine.
Informed consent statement: All study participants or their legal guardians signed written informed consent forms.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Fu-Quan Liu, BCPS, MD, Director, Professor, Department of Interventional Therapy, Peking University Ninth School of Clinical Medicine, Beijing Shijitan Hospital, No. 10 Tie Yi Road, Yangfangdian, Haidian District, Beijing 100038, China. lfuquan@aliyun.com
Received: December 1, 2021
Peer-review started: December 1, 2021
First decision: April 16, 2022
Revised: April 21, 2022
Accepted: May 21, 2022
Article in press: May 21, 2022
Published online: June 27, 2022
Processing time: 207 Days and 22.6 Hours
Core Tip

Core Tip: We adequately evaluated whether transjugular intrahepatic portosystemic shunt combined with radioactive seed strand placement was safe in adverse events and effective in portal vein tumor thrombosis response and prolonging survival time for the treatment of patients with main portal vein tumor thrombosis and cirrhotic portal hypertension through a retrospective cohort study with 2 years of follow-up.